CC BY-NC-ND 4.0 · Endosc Int Open 2025; 13: a24947333
DOI: 10.1055/a-2494-7333
Review

On-site ERCP availability and cholangitis outcomes: Retrospective cohort study

1   Department of Medicine, University of Toronto, Toronto, Canada (Ringgold ID: RIN7938)
,
Kayley-Jasmin Marchena-Romero
2   GEMINI, St Michael's Hospital Li Ka Shing Knowledge Institute, Toronto, Canada (Ringgold ID: RIN518773)
,
Marwa F. Ismail
2   GEMINI, St Michael's Hospital Li Ka Shing Knowledge Institute, Toronto, Canada (Ringgold ID: RIN518773)
,
Surain B. Roberts
2   GEMINI, St Michael's Hospital Li Ka Shing Knowledge Institute, Toronto, Canada (Ringgold ID: RIN518773)
,
Nikko Gimpaya
3   Division of Gastroenterology, Scarborough Health Network, Scarborough, Canada (Ringgold ID: RIN507265)
,
4   Department of Medicine, Queen's University, Kingston, Canada (Ringgold ID: RIN4257)
,
Nasruddin Sabrie
1   Department of Medicine, University of Toronto, Toronto, Canada (Ringgold ID: RIN7938)
,
5   Division of Gastroenterology, St Michael's Hospital, Toronto, Canada (Ringgold ID: RIN10071)
6   Department of Gastroenterology, IRCCS Humanitas Research Hospital Department of Gastroenterology, Rozzano, Italy (Ringgold ID: RIN551905)
,
Jeffrey Mosko
5   Division of Gastroenterology, St Michael's Hospital, Toronto, Canada (Ringgold ID: RIN10071)
,
Paul James
7   Medicine, The University Health Network, Toronto, Canada
,
Nauzer Forbes
8   Medicine, University of Calgary, Calgary, Canada
,
Fahad Razak
9   Department of Medicine, St Michael's Hospital, Toronto, Canada (Ringgold ID: RIN10071)
,
Amol A. Verma
9   Department of Medicine, St Michael's Hospital, Toronto, Canada (Ringgold ID: RIN10071)
,
Samir C. Grover
3   Division of Gastroenterology, Scarborough Health Network, Scarborough, Canada (Ringgold ID: RIN507265)
› Author Affiliations

Supported by: St. Michael’s Hospital Foundation Association Innovation Fund Award

Abstract

Background and study aims

Endoscopic retrograde cholangiopancreatography (ERCP) is important in acute cholangitis (AC) management but is not available at all hospitals. The association between on-site ERCP availability and cholangitis outcomes is unknown.

Patients and methods

We included adults diagnosed with AC at 27 hospitals in Ontario through the GEMINI network. We collected data on demographics, clinical and laboratory values, and interventions. The primary outcome was in-hospital mortality. Secondary outcomes were length of stay, intensive care unit (ICU) admission, readmission rates, and requirement for percutaneous or surgical decompression. We used multivariable regression analyses to assess the impact of on-site ERCP availability on the primary and secondary outcomes with adjustment for relevant variables.

Results

Our cohort included 4492 patients with a median age of 75. Patients at ERCP sites had higher unadjusted rates of undergoing ERCP (55.7% at ERCP sites, 40.8% at non-ERCP sites). Patients at ERCP sites compared with non-ERCP sites did not have significantly different in-hospital mortality (adjusted odds ratio [aOR] = 2.19, 95% confidence interval [CI] = 0.86–5.55). Compared with non-ERCP sites, patients at ERCP sites with underlying stricturing biliary disease or pancreaticobiliary malignancy (aOR = 1.94, 95% CI = 1.14–13.58) or severe cholangitis (aOR = 2.17, 95% CI = 1.17–4.02) had higher odds of in-hospital mortality. In a post-hoc propensity score-based analysis, there was no significant difference between patients at ERCP sites compared with those at non-ERCP sites for in-hospital mortality.

Conclusions

Patients at ERCP sites compared with non-ERCP sites did not have significantly different mortality. Subgroups of patients with underlying stricturing biliary disease or pancreaticobiliary malignancy and severe cholangitis, who have higher mortality at ERCP sites, warrant further study.

Supplementary Material



Publication History

Received: 15 April 2024

Accepted after revision: 05 November 2024

Accepted Manuscript online:
02 December 2024

Article published online:
29 January 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Bibliographical Record
Rishad Khan, Kayley-Jasmin Marchena-Romero, Marwa F. Ismail, Surain B. Roberts, Nikko Gimpaya, Michael A. Scaffidi, Nasruddin Sabrie, Kareem Khalaf, Jeffrey Mosko, Paul James, Nauzer Forbes, Fahad Razak, Amol A. Verma, Samir C. Grover. On-site ERCP availability and cholangitis outcomes: Retrospective cohort study. Endosc Int Open 2025; 13: a24947333.
DOI: 10.1055/a-2494-7333
 
  • References

  • 1 Kiriyama S, Kozaka K, Takada T. et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci 2018; 25: 17-30
  • 2 Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol 2009; 6: 533-541
  • 3 Mosler P. Diagnosis and management of acute cholangitis. Curr Gastroenterol Rep 2011; 13: 166-172
  • 4 Lee F, Ohanian E, Rheem J. et al. Delayed endoscopic retrograde cholangiopancreatography is associated with persistent organ failure in hospitalised patients with acute cholangitis. Aliment Pharmacol Ther 2015; 42: 212-220
  • 5 Tan M, Schaffalitzky de Muckadell OB, Laursen SB. Association between early ERCP and mortality in patients with acute cholangitis. Gastrointest Endosc 2018; 87: 185-192
  • 6 Iqbal U, Khara HS, Hu Y. et al. Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis. Gastrointest Endosc 2020; 91: 753-760 e4
  • 7 Hou LA, Laine L, Motamedi N. et al. Optimal timing of endoscopic retrograde cholangiopancreatography in acute cholangitis. J Clin Gastroenterol 2017; 51: 534-538
  • 8 Parikh MP, Wadhwa V, Thota PN. et al. Outcomes associated with timing of ERCP in acute cholangitis secondary to choledocholithiasis. J Clin Gastroenterol 2018; 52: e97-e102
  • 9 Andriulli A, Loperfido S, Napolitano G. et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102: 1781-1788
  • 10 Varadarajulu S, Kilgore ML, Wilcox CM. et al. Relationship among hospital ERCP volume, length of stay, and technical outcomes. Gastrointest Endosc 2006; 64: 338-347
  • 11 Coté GA, Imler TD, Xu H. et al. Lower provider volume is associated with higher failure rates for endoscopic retrograde cholangiopancreatography. Med Care 2013; 51
  • 12 Verma AA, Guo Y, Kwan JL. et al. Patient characteristics, resource use and outcomes associated with general internal medicine hospital care: the General Medicine Inpatient Initiative (GEMINI) retrospective cohort study. CMAJ open 2017; 5: E842
  • 13 Von Elm E, Altman DG, Egger M. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457
  • 14 Verma AA, Pasricha SV, Jung HY. et al. Assessing the quality of clinical and administrative data extracted from hospitals: the General Medicine Inpatient Initiative (GEMINI) experience. J Am Med Inform Assoc 2021; 28: 578-587
  • 15 Canadian Institute for Health Information. Discharge abstract data metadata. https://www.cihi.ca/en/discharge-abstract-database-metadata-dad
  • 16 Canadian Institute for Health Information. National Ambulatory Care Reporting System metadata (NACRS). https://www.cihi.ca/en/national-ambulatory-care-reporting-system-metadata-nacrs
  • 17 Khan R, Saha S, Gimpaya N. et al. Outcomes for upper gastrointestinal bleeding during the first wave of the COVID-19 pandemic in the Toronto area. J Gastroenterol Hepatol 2022; 37: 878-882
  • 18 Forbes N, Elmunzer BJ, Keswani RN. et al. Consensus-based development of a causal attribution system for post-ERCPadverse events. Gut 2022; 71: 1963-1966
  • 19 Charlson M, Szatrowski TP, Peterson J. et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251
  • 20 Waters R, Malecki S, Lail S. et al. Automated identification of unstandardized medication data: a scalable and flexible data standardization pipeline using RxNorm on GEMINI multicenter hospital data. JAMIA open 2023; 6: ooad062
  • 21 Therneau T. A package for survival analysis in R. R package version 3.5–7. 2023.
  • 22 Harrell F. Regression modeling strategies. R package version 6.4–1. 2023.
  • 23 Venables W, Ripley B. Modern applied statistics with S. Fourth Edition. New York, NY, United States: Springer; 2002
  • 24 Kassambara A, Kosinski M, Biecek P. et al. Drawing survival curves using ‘ggplot2’. R package version 0.4.9. 2021.
  • 25 R Core Team. R: A language and environment for statistical computing. 2010. https://lib.stat.cmu.edu/R/CRAN/doc/manuals/r-devel/fullrefman.pdf
  • 26 Acehan F, Çamlı H, Kalkan C. et al. Characteristics and clinical outcomes of acute cholangitis in older patients. Eur Geriatr Med 2023; 14: 263-273
  • 27 Inamdar S, Sejpal DV, Ullah M. et al. Weekend vs. weekday admissions for cholangitis requiring an ERCP: Comparison of outcomes in a national cohort. Am J Gastroenterol 2016; 111: 405-410
  • 28 Li F, Thomas LE, Li F. Addressing extreme propensity scores via the overlap weights. Am J Epidemiol 2019; 188: 250-257
  • 29 Wang M, Wadhwani SI, Cullaro G. et al. Racial and ethnic disparities among patients hospitalized for acute cholangitis in the United States. J Clin Gastroenterol 2023; 57: 731-736